Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus - BioSpace
- Moderna has launched a first-in-human Phase 1 clinical trial (NCT07737717) for mRNA-1469, an investigational vaccine targeting the Bundibugyo ebolavirus (BDBV).
- The study is being conducted across three sites in Canada and aims to enroll approximately 80 healthy adult participants to evaluate safety, tolerability, and immunogenicity.
- This development is critical because while vaccines exist for Zaire ebolavirus, there are currently no approved vaccines to protect against BDBV, which has caused outbreaks in the Democratic Republic of the Congo.
- The trial represents the initial step in determining if this mRNA-based candidate can provide a viable defense against a specific strain of Ebola disease.
Sources & Citations
1 sourceMore Stories
Medicine News
• A survey of Alberta healthcare workers revealed that many staff members experienced coercion and moral injury resulting from COVID-19 vaccine mandates. • The findings highlight the psychological impact on medical professionals who felt forced to comply with mandates to maintain their employment.
Read original · archive.isMedical News
• Clinicians are raising alarms over the sale of direct-to-consumer emergency kits that contain prescription drugs and antibiotics. • These kits allow individuals to purchase potent medications without a doctor's oversight or a valid prescription.
Read original · archive.liWhat went right this week: the good news that matters - Positive News
• The World Health Organization recognized a historic achievement in the global effort to stop dog-transmitted rabies through vaccination and surveillance. • WHO Director General Tedros Adhanom Ghebreyesus credited the success to more than five decades of sustained investment in public health.
Read original · positive.news
Positive NewsGlobal health update: September 16, 2026
• The World Health Organization reported on September 10 that the Democratic Republic of the Congo is experiencing the fastest-growing Ebola outbreak on record. • Health officials have confirmed more than 6,700 cases and more than 3,200 deaths during this current surge.
Read original · bushcenter.org
George W. Bush Presidential CenterReuters Health News Summary
• Xenon Pharmaceuticals paused new patient enrollment in clinical trials for its experimental major and bipolar depression drug on Thursday. • The company halted the studies following reports of side effects related to the mental and nervous system.
Read original · bundle.appRFK Jr. Children's Health Defense, NIH grants: Morning Rounds
• Robert F. Kennedy Jr. is scheduled to speak at a conference hosted by the Children's Health Defense organization. • The event is part of a broader series of health news updates including research on protecting heart health in outer space.
Read original · statnews.com
StatnewsThe Drugs and Devices Have Been on the Market for Years. But FDA-Ordered Studies Still Aren’t Done. - KFF Health News
• The FDA has allowed companies to sell drugs and devices while completing safety and efficacy studies, but many of these postmarket requirements are now overdue or behind schedule. • FDA leaders announced in February that the default requirement for agency approvals will shift to one clinical trial instead of two.
Read original · kffhealthnews.org
KFF Health NewsFour measles deaths, a looming policy comment deadline, and how to read a study: The State of US Vaccine Policy
• The U.S. Food and Drug Administration approved this season's COVID vaccines nearly three weeks ago for general use. • Children with private insurance can currently access the shots, but those in the Vaccines for Children program must wait for Health and Human Services sign-off.
Read original · cidrap.umn.eduPhiladelphia health officials report a measles exposure at CHOP
• Philadelphia health officials reported a potential measles exposure at the Children's Hospital of Philadelphia on September 11. • The exposure occurred in the neonatal intensive care unit and other locations at the hospital's 3401 Civic Center Blvd facility.
Read original · inquirer.comFDA-ordered studies of many drugs, devices on the market are not done - The Washington Post
• The FDA has allowed many pharmaceutical companies to delay or ignore required safety and efficacy studies for drugs and devices already on the market. • Agency records show that these "postmarket" studies, intended to verify a product's performance after approval, are frequently behind schedule or overdue.
Read original · washingtonpost.comThe FDA requires follow-up studies for drugs and devices. Years later, many still aren’t done - Government Executive
• An analysis of FDA data revealed that hundreds of required postmarket studies for drugs and medical devices are running behind schedule. • The findings indicate that many manufacturers have failed to complete follow-up research mandated by the agency years after product approval.
Read original · govexec.com
Government ExecutiveAdvocates, lawmakers call for release of congressionally approved global health funds
• Lawmakers and advocates are calling on the Trump administration to release over $1 billion in congressionally approved global health funding. • An analysis by Partners in Health shows the Office of Management and Budget is withholding $1.35 billion in bilateral funds.
Read original · cidrap.umn.edu